Listed by the USPTO as COLEMAN, BRENDA LIBBY
Tech Center 2800 • Art Units: 1600 1614 1624 1626 1629 1644 2897
This examiner grants 75% of resolved cases
COLEMAN, BRENDA LIBBY is a USPTO patent examiner in tech center 2800 and art unit 1600. The profile includes 1649 resolved cases, a 74.8% allowance rate, a 15.7% interview lift, and a median of 884 days to allowance. The high case volume gives the figures substantial historical context, while the positive interview result supports considering direct discussion as one element of a broader strategy.
The listed companies are Nocion Therapeutics Inc., Hoffmann-La Roche Inc., and Novartis AG. The listed firms are COOLEY LLP, ELMORE PATENT LAW GROUP, PC, and FISH & RICHARDSON P.C. (TC). The company and firm lists identify representative pharmaceutical and biotechnology prosecution experience.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18741024 | SOLVATE AND METHOD OF MANUFACTURING SOLVATE | Non-Final OA | FUJIFILM Corporation |
| 17768508 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Non-Final OA | Merck Patent GmbH |
| 17625059 | TREATMENT OF PULMONARY FIBROSIS USING INHIBITORS OF NEU1 SIALIDASE | Non-Final OA | The United States Government as represented by the Department of Veterans Affairs |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy74.8% of resolved applications examined by Brenda Libby Coleman were allowed (1,649 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +15.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Brenda Libby Coleman took 884 days on average from filing to allowance.
Brenda Libby Coleman examines applications in Art Unit 1600 in Tech Center 2800 (Semiconductors, Circuits & Optics).
